» Articles » PMID: 24454937

Lipid Metabolism, Oxidative Stress and Cell Death Are Regulated by PKC Delta in a Dietary Model of Nonalcoholic Steatohepatitis

Overview
Journal PLoS One
Date 2014 Jan 24
PMID 24454937
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Steatosis, oxidative stress, and apoptosis underlie the development of nonalcoholic steatohepatitis (NASH). Protein kinase C delta (PKCδ) has been implicated in fatty liver disease and is activated in the methionine and choline-deficient (MCD) diet model of NASH, yet its pathophysiological importance towards steatohepatitis progression is uncertain. We therefore addressed the role of PKCδ in the development of steatosis, inflammation, oxidative stress, apoptosis, and fibrosis in an animal model of NASH. We fed PKCδ(-/-) mice and wildtype littermates a control or MCD diet. PKCδ(-/-) primary hepatocytes were used to evaluate the direct effects of fatty acids on hepatocyte lipid metabolism gene expression. A reduction in hepatic steatosis and triglyceride levels were observed between wildtype and PKCδ(-/-) mice fed the MCD diet. The hepatic expression of key regulators of β-oxidation and plasma triglyceride metabolism was significantly reduced in PKCδ(-/-) mice and changes in serum triglyceride were blocked in PKCδ(-/-) mice. MCD diet-induced hepatic oxidative stress and hepatocyte apoptosis were reduced in PKCδ(-/-) mice. MCD diet-induced NADPH oxidase activity and p47(phox) membrane translocation were blunted and blocked, respectively, in PKCδ(-/-) mice. Expression of pro-apoptotic genes and caspase 3 and 9 cleavage in the liver of MCD diet fed PKCδ(-/-) mice were blunted and blocked, respectively. Surprisingly, no differences in MCD diet-induced fibrosis or pro-fibrotic gene expression were observed in 8 week MCD diet fed PKCδ(-/-) mice. Our results suggest that PKCδ plays a role in key pathological features of fatty liver disease but not ultimately in fibrosis in the MCD diet model of NASH.

Citing Articles

Upregulation of rate-limiting enzymes in cholesterol metabolism by PKCδ mediates endothelial apoptosis in diabetic wound healing.

Qin P, Zhou P, Huang Y, Long B, Gao R, Zhang S Cell Death Discov. 2024; 10(1):263.

PMID: 38811564 PMC: 11137154. DOI: 10.1038/s41420-024-02030-2.


Experimental Models for Studying Structural and Functional State of the Pathological Liver (Review).

Krylov D, Rodimova S, Karabut M, Kuznetsova D Sovrem Tekhnologii Med. 2024; 15(4):65-82.

PMID: 38434194 PMC: 10902899. DOI: 10.17691/stm2023.15.4.06.


Once a week consumption of Western diet over twelve weeks promotes sustained insulin resistance and non-alcoholic fat liver disease in C57BL/6 J mice.

Demaria T, Crepaldi L, Costa-Bartuli E, Branco J, Zancan P, Sola-Penna M Sci Rep. 2023; 13(1):3058.

PMID: 36810903 PMC: 9942638. DOI: 10.1038/s41598-023-30254-2.


Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research.

Flessa C, Nasiri-Ansari N, Kyrou I, Leca B, Lianou M, Chatzigeorgiou A Int J Mol Sci. 2022; 23(24).

PMID: 36555433 PMC: 9780957. DOI: 10.3390/ijms232415791.


The metabolomics of a protein kinase C delta (PKCδ) knock-out mouse model.

Loots D, Adeniji A, van Reenen M, Ozturk M, Brombacher F, Parihar S Metabolomics. 2022; 18(11):92.

PMID: 36371785 PMC: 9660189. DOI: 10.1007/s11306-022-01949-w.


References
1.
Feldstein A, Gores G . Steatohepatitis and apoptosis: therapeutic implications. Am J Gastroenterol. 2004; 99(9):1718-9. DOI: 10.1111/j.1572-0241.2004.40573.x. View

2.
Anstee Q, Goldin R . Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol. 2006; 87(1):1-16. PMC: 2517349. DOI: 10.1111/j.0959-9673.2006.00465.x. View

3.
Li Z, Soloski M, Diehl A . Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology. 2005; 42(4):880-5. DOI: 10.1002/hep.20826. View

4.
Bokoch G, Diebold B, Kim J, Gianni D . Emerging evidence for the importance of phosphorylation in the regulation of NADPH oxidases. Antioxid Redox Signal. 2009; 11(10):2429-41. PMC: 2821133. DOI: 10.1089/ars.2009.2590. View

5.
Jou J, Choi S, Diehl A . Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis. 2008; 28(4):370-9. DOI: 10.1055/s-0028-1091981. View